Elios Therapeutics, Llc

This trial tested a personalized cancer vaccine made from a patient's own tumor cells. It aimed to see if the vaccine could slow tumor growth, improve survival, and trigger an immune response. The study included 63 adults with various solid tumors, but was stopped early.